Bumetanide

Product manufactured by Bryant Ranch Prepack

Application Nr Approved Date Route Status External Links
ANDA074700 1996-11-21 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Bumetanide Tablets, Usp Are Indicated For The Treatment Of Edema Associated With Congestive Heart Failure, Hepatic And Renal Disease, Including The Nephrotic Syndrome. Almost Equal Diuretic Response Occurs After Oral And Parenteral Administration Of Bumetanide. Therefore, If Impaired Gastrointestinal Absorption Is Suspected Or Oral Administration Is Not Practical, Bumetanide Should Be Given By The Intramuscular Or Intravenous Route. Successful Treatment With Bumetanide Tablets, Usp Following Instances Of Allergic Reactions To Furosemide Suggests A Lack Of Cross-Sensitivity.

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Anhydrous Lactose ANHYDROUS LACTOSE Molecular
2. Starch, Corn STARCH, CORN Unresolved
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Talc TALC Unresolved DYE-Dye GRAS-Generally recognized as safe.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bumetanide BUMETANIDE ZINC3813061

Comments